Susanna Gatti High - Net Worth and Insider Trading

Susanna Gatti High Net Worth

The estimated net worth of Susanna Gatti High is at least $5 Million dollars as of 2024-06-06. Susanna Gatti High is the COO of Dyne Therapeutics Inc and owns about 154,062 shares of Dyne Therapeutics Inc (DYN) stock worth over $5 Million. Susanna Gatti High is also the COO of bluebird bio Inc and owns about 13,735 shares of bluebird bio Inc (BLUE) stock worth over $12,607. Details can be seen in Susanna Gatti High's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Susanna Gatti High has not made any transactions after 2024-05-16 and currently still holds the listed stock(s).

Transaction Summary of Susanna Gatti High

To

Susanna Gatti High Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Susanna Gatti High owns 2 companies in total, including Dyne Therapeutics Inc (DYN) , and bluebird bio Inc (BLUE) .

Click here to see the complete history of Susanna Gatti High’s form 4 insider trades.

Insider Ownership Summary of Susanna Gatti High

Ticker Comapny Transaction Date Type of Owner
DYN Dyne Therapeutics Inc 2024-05-16 Chief Operating Officer
BLUE bluebird bio Inc 2018-12-06 Chief Operating Officer

Susanna Gatti High Latest Holdings Summary

Susanna Gatti High currently owns a total of 2 stocks. Among these stocks, Susanna Gatti High owns 154,062 shares of Dyne Therapeutics Inc (DYN) as of May 16, 2024, with a value of $5 Million and a weighting of 99.75%. Susanna Gatti High also owns 13,735 shares of bluebird bio Inc (BLUE) as of December 6, 2018, with a value of $12,607 and a weighting of 0.25%.

Latest Holdings of Susanna Gatti High

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
DYN Dyne Therapeutics Inc 2024-05-16 154,062 32.78 5,050,152
BLUE bluebird bio Inc 2018-12-06 13,735 0.92 12,607

Holding Weightings of Susanna Gatti High


Susanna Gatti High Form 4 Trading Tracker

According to the SEC Form 4 filings, Susanna Gatti High has made a total of 11 transactions in Dyne Therapeutics Inc (DYN) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Dyne Therapeutics Inc is the sale of 2,738 shares on May 16, 2024, which brought Susanna Gatti High around $77,403.

According to the SEC Form 4 filings, Susanna Gatti High has made a total of 0 transactions in bluebird bio Inc (BLUE) over the past 5 years. The most-recent trade in bluebird bio Inc is the sale of 1,875 shares on December 6, 2018, which brought Susanna Gatti High around $198,206.

Insider Trading History of Susanna Gatti High

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Susanna Gatti High Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Susanna Gatti High Ownership Network

Ownership Network List of Susanna Gatti High

No Data

Ownership Network Relation of Susanna Gatti High

Insider Network Chart

Susanna Gatti High Owned Company Details

What does Dyne Therapeutics Inc do?

Who are the key executives at Dyne Therapeutics Inc?

Susanna Gatti High is the Chief Operating Officer of Dyne Therapeutics Inc. Other key executives at Dyne Therapeutics Inc include See Remarks Oxana Beskrovnaya , See Remarks Richard William Scalzo , and Chief Medical Officer Wildon Farwell .

Dyne Therapeutics Inc (DYN) Insider Trades Summary

Over the past 18 months, Susanna Gatti High made 10 insider transaction in Dyne Therapeutics Inc (DYN) with a net sale of 53,617. Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 244,099 shares made by Jonathan Mcneill , a net sale of 194,534 shares made by Richard William Scalzo , and a net sale of 133,322 shares made by Oxana Beskrovnaya .

In summary, during the past 3 months, insiders sold 733,732 shares of Dyne Therapeutics Inc (DYN) in total and bought 0 shares, with a net sale of 733,732 shares. During the past 18 months, 5,516,515 shares of Dyne Therapeutics Inc (DYN) were sold and 3,583,447 shares were bought by its insiders, resulting in a net sale of 1,933,068 shares.

Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Dyne Therapeutics Inc Insider Transactions

No Available Data

Susanna Gatti High Mailing Address

Above is the net worth, insider trading, and ownership report for Susanna Gatti High. You might contact Susanna Gatti High via mailing address: 75 Lorimer Road, Belmont Ma 02141.

Discussions on Susanna Gatti High

No discussions yet.